Bio-Path Holdings Inc
BPTH
BPTH was delisted on the 18th of February, 2025.
19 hedge funds and large institutions have $276K invested in Bio-Path Holdings Inc in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 5 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
8% more capital invested
Capital invested by funds: $257K → $276K (+$19.8K)
10% less funds holding
Funds holding: 21 → 19 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$62K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$12.7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$12K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$8.42K |
| 5 |
BlackRock
New York
|
+$3.28K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
-$77.4K |
| 2 |
Renaissance Technologies
New York
|
-$9K |
| 3 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$8.88K |
| 4 |
Millennium Management
New York
|
-$6.87K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.75K |
BPTH Hedge Fund Activity: Q4 2023 in Review
19 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q4 2023, worth a combined $276K — up 7.7% from $257K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of BPTH and 3 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 5 added.
The largest buyer was Vanguard Group, adding an estimated $62K. The largest seller was Walleye Capital, exiting entirely with an estimated $77.4K sold.
- 19 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q4 2023, down from 21 in Q3 2023.
- Funds reported $276K of Bio-Path Holdings Inc stock for Q4 2023, up 7.7% quarter-over-quarter.
- 3 funds opened new Bio-Path Holdings Inc positions in Q4 2023 and 5 closed out, a net change of -2 holders.
- The largest Bio-Path Holdings Inc buyer in Q4 2023 was Vanguard Group, an estimated $62K added.
- The largest Bio-Path Holdings Inc seller in Q4 2023 was Walleye Capital, an estimated $77.4K sold.
Based on aggregated 13F filings for Q4 2023.